Gen Wealth Partners Inc Decreases Stake in Kenvue Inc. (NYSE:KVUE)

Gen Wealth Partners Inc lessened its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 2.8% during the 4th quarter, HoldingsChannel reports. The firm owned 25,173 shares of the company’s stock after selling 731 shares during the period. Gen Wealth Partners Inc’s holdings in Kenvue were worth $537,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Price T Rowe Associates Inc. MD increased its stake in shares of Kenvue by 3.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 245,885,918 shares of the company’s stock worth $5,249,665,000 after acquiring an additional 8,211,748 shares during the last quarter. Vanguard Group Inc. increased its position in Kenvue by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 218,543,705 shares of the company’s stock worth $4,665,908,000 after purchasing an additional 1,636,741 shares during the last quarter. Massachusetts Financial Services Co. MA raised its stake in Kenvue by 12.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 97,661,344 shares of the company’s stock worth $2,085,070,000 after purchasing an additional 10,682,003 shares during the period. Geode Capital Management LLC boosted its holdings in Kenvue by 3.1% in the 4th quarter. Geode Capital Management LLC now owns 46,068,931 shares of the company’s stock valued at $980,989,000 after purchasing an additional 1,391,854 shares during the last quarter. Finally, Franklin Resources Inc. grew its stake in shares of Kenvue by 61.5% in the 4th quarter. Franklin Resources Inc. now owns 42,719,377 shares of the company’s stock valued at $912,059,000 after buying an additional 16,269,721 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently commented on KVUE. Piper Sandler lifted their price target on shares of Kenvue from $24.00 to $27.00 and gave the company an “overweight” rating in a research report on Monday, February 24th. Citigroup upped their target price on shares of Kenvue from $22.00 to $24.50 and gave the stock a “neutral” rating in a research note on Friday. Redburn Atlantic began coverage on Kenvue in a research report on Thursday, April 10th. They issued a “neutral” rating and a $23.50 price target on the stock. Royal Bank of Canada reissued a “sector perform” rating and set a $24.00 price objective on shares of Kenvue in a research report on Monday, February 3rd. Finally, Evercore ISI started coverage on shares of Kenvue in a report on Monday, March 24th. They issued an “in-line” rating and a $25.00 target price on the stock. Seven analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, Kenvue currently has a consensus rating of “Hold” and a consensus target price of $25.25.

Kenvue Stock Performance

Shares of KVUE opened at $24.47 on Friday. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 52-week low of $17.67 and a 52-week high of $25.17. The stock has a 50 day moving average price of $23.13 and a 200 day moving average price of $22.56. The company has a market capitalization of $46.95 billion, a price-to-earnings ratio of 46.17, a price-to-earnings-growth ratio of 2.62 and a beta of 1.02.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, May 8th. The company reported $0.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.01. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. The business had revenue of $3.74 billion during the quarter, compared to analysts’ expectations of $3.69 billion. During the same quarter in the prior year, the business posted $0.28 EPS. The company’s revenue for the quarter was down 3.9% on a year-over-year basis. Research analysts predict that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th will be given a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.35%. The ex-dividend date is Wednesday, May 14th. Kenvue’s dividend payout ratio (DPR) is currently 154.72%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.